Anxiety and Depression

October 18, 2018

Repurposing the anesthetic agent Sevoflurane as an anxiety-reducing agent: Sevoflurane (Trade name: Sojourn, Ultane, Sevorane) decreases PHF8 levels, increases the expression of serotonin receptors Htr1a and Htr2a, and promotes resistance to stress-induced -anxiety and -depression, via down-regulation of its target gene, 18/October/2018, 5.59 am

Repurposing the anesthetic agent Sevoflurane as an anxiety-reducing agent: Sevoflurane (Trade name: Sojourn, Ultane, Sevorane) decreases PHF8 levels, increases the expression of serotonin receptors Htr1a and Htr2a, and promotes resistance to stress-induced -anxiety and -depression, via down-regulation of its target gene, 18/October/2018, 5.59 am https://genomediscovery.org/wp-content/uploads/2018/10/Anesthetic-agent-Sevolfurane-fns-as-an-antianxity-agent-through-upregulation-of-5HTR1A.B2A8-1.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2018/10/Anesthetic-agent-Sevolfurane-fns-as-an-antianxity-agent-through-upregulation-of-5HTR1A.B2A8-1.jpg October 18, 2018 October 18, 2018

Introduction: What they say: A study from Department of Molecular Biology, Cancer Center and Center for Regenerative Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA; Department of Stem Cell and…

October 18, 2018

Anesthetic agents as anxiety-reducing agents: Midazolam, an anesthetic agent, decreases PHF8 levels, increases the expression of serotonin receptors Htr1a and Htr2a, and promotes resistance to stress-induced -anxiety and -depression, via down-regulation of its target gene, 18/October/2018, 5.44 am

Anesthetic agents as anxiety-reducing agents: Midazolam, an anesthetic agent, decreases PHF8 levels, increases the expression of serotonin receptors Htr1a and Htr2a, and promotes resistance to stress-induced -anxiety and -depression, via down-regulation of its target gene, 18/October/2018, 5.44 am https://genomediscovery.org/wp-content/uploads/2018/10/Anesthetic-agent-Midazolam-fns-as-an-antianxity-agent-through-upregulation-of-5HTR1A.B2A.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2018/10/Anesthetic-agent-Midazolam-fns-as-an-antianxity-agent-through-upregulation-of-5HTR1A.B2A.jpg October 18, 2018 October 18, 2018

September 30, 2018

A probiotic way to quench anxiety and depression: Probiotic lactobacillus Rhamnousus decreases PHF8 levels, increases the expression of serotonin receptors Htr1a and Htr2a, and promotes resistance to stress-induced -anxiety and -depression, via down-regulation of its target gene, 1/October/2018, 12.16 am

A probiotic way to quench anxiety and depression: Probiotic lactobacillus Rhamnousus decreases PHF8 levels, increases the expression of serotonin receptors Htr1a and Htr2a, and promotes resistance to stress-induced -anxiety and -depression, via down-regulation of its target gene, 1/October/2018, 12.16 am https://genomediscovery.org/wp-content/uploads/2018/09/Probiotics-Lactobacillus-Rhamnosus-inhibits-PHF8.JMJD1-fns-as-an-antidepressant.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2018/09/Probiotics-Lactobacillus-Rhamnosus-inhibits-PHF8.JMJD1-fns-as-an-antidepressant.jpg September 30, 2018 October 1, 2018

September 27, 2018

A statin-based drug stifles anxiety and depression: Cerivastatin, a lipid-lowering agent, decreases PHF8 levels, increases the expression of serotonin receptors Htr1a and Htr2a, and promotes resistance to stress-induced -anxiety and -depression, via down-regulation of its target gene, 27/September/2018, 7.14 pm

A statin-based drug stifles anxiety and depression: Cerivastatin, a lipid-lowering agent, decreases PHF8 levels, increases the expression of serotonin receptors Htr1a and Htr2a, and promotes resistance to stress-induced -anxiety and -depression, via down-regulation of its target gene, 27/September/2018, 7.14 pm https://genomediscovery.org/wp-content/uploads/2018/09/Cerivastatin-inhibits-PHF8.JMJD1_.2-expression-increases-Seratonin-receptor-levels-and-attenuates-anxiety-and-depression.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2018/09/Cerivastatin-inhibits-PHF8.JMJD1_.2-expression-increases-Seratonin-receptor-levels-and-attenuates-anxiety-and-depression.jpg September 27, 2018 September 27, 2018

September 26, 2018

Mechanistic insights into how a statin-based drug stifles anxiety and depression: Simvastatin, a lipid-lowering agent, decreases PHF8 levels, increases the expression of serotonin receptors Htr1a and Htr2a, and promotes resistance to stress-induced -anxiety and -depression, via down-regulation of its target gene, 26/September/2018, 11.22 pm

Mechanistic insights into how a statin-based drug stifles anxiety and depression: Simvastatin, a lipid-lowering agent, decreases PHF8 levels, increases the expression of serotonin receptors Htr1a and Htr2a, and promotes resistance to stress-induced -anxiety and -depression, via down-regulation of its target gene, 26/September/2018, 11.22 pm https://genomediscovery.org/wp-content/uploads/2018/09/Simvastatin-inhibits-PHF8.JMJD1_.2-expression-increases-Seratonin-receptors-5HTR1A.jpg-and-attenuates-anxiety-and-depression.jpg2_.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2018/09/Simvastatin-inhibits-PHF8.JMJD1_.2-expression-increases-Seratonin-receptors-5HTR1A.jpg-and-attenuates-anxiety-and-depression.jpg2_.jpg September 26, 2018 September 26, 2018

September 21, 2018

A derivative of sulfamoylated Estrone comes to the rescue of anxiety and depression: 2-Ethylestrone-3-O-sulfamate (2EtEMATE) decreases PHF8 levels, increases the expression of serotonin receptors Htr1a and Htr2a, and promotes resistance to stress-induced -anxiety and -depression, via down-regulation of its target gene, 21/September/2018, 11.00 pm

A derivative of sulfamoylated Estrone comes to the rescue of anxiety and depression: 2-Ethylestrone-3-O-sulfamate (2EtEMATE) decreases PHF8 levels, increases the expression of serotonin receptors Htr1a and Htr2a, and promotes resistance to stress-induced -anxiety and -depression, via down-regulation of its target gene, 21/September/2018, 11.00 pm https://genomediscovery.org/wp-content/uploads/2018/09/2-EtEMATE-inhibits-PHF8.JMJD1_.2-expression-increases-Seratonin-receptors-and-attenuates-anxiety-and-depression.jpg2_.jpg4_.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2018/09/2-EtEMATE-inhibits-PHF8.JMJD1_.2-expression-increases-Seratonin-receptors-and-attenuates-anxiety-and-depression.jpg2_.jpg4_.jpg September 21, 2018 September 21, 2018

Anesthetic agents as anxiety-reducing agents: Midazolam, an anesthetic agent, decreases PHF8 levels, increases the expression of serotonin receptors Htr1a and Htr2a, and promotes resistance to stress-induced -anxiety and -depression, via down-regulation of its target gene, 18/October/2018, 5.44 am

Popular Post